Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

PMG Research of Winston-Salem, Winston-Salem

Clinical Research of Homestead, Homestead

Clinical Research Associates, LLC, Huntsville

E Squared Research, Inc., Huntsville

Clinsearch, Chattanooga

New Phase Research & Development, Knoxville

Great Lakes Medical Research, Mentor

Arkansas Gastroenterology, P.A., North Little Rock

Endoscoopy Center of AR, Little Rock

Aztec Medical Research, LLC, Channelview

Gastroenterology Research of San Antonio, San Antonio

Shahram Jacobs MD, Inc., Sherman Oaks

Providence Clinical Research, North Hollywood

Advanced Rx Clinical Research Group, Inc., Westminster

Prx Clinical, Garden Grove

Bristol Hospital Dba Connecticut Gastroenterology Institute, Bristol